Refractory constipation and megacolon in MEN 2b

Digestive Diseases and Sciences

Volumn 41, Issue 11, 1996, Pages 2233-2237

  Dunzendorfer, Thomas ^a   Lee, Victor W ^a   Levine, Sharon ^a   De Las Morenas, Antonio ^a   Beazley, Robert M ^a   Chipkin, Stuart ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Constipation; Megacolon; Multiple endocrine neoplasia 2b; Thyroid nodules

Indexed keywords

CALCITONIN; METADRENALIN; METIROSINE;

ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; FEMALE; GANGLIONEUROMA; HUMAN; MARFAN SYNDROME; MEGACOLON; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RADIOLOGY;

EID: 0029825361     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02071406     Document Type: Article

References (17)

1. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ: Functional constipation and outlet delay, a population-based study. Gastroenterology 105:781-790, 1993
2. Schimke RN, Hartmann WH, Prout TE, Rimoin TL: Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. N Engl J Med 279:1-7, 1968
3. Carney JA, Go VLW, Sizemore GW, Hayles AB: Alimentarytract ganglioneuromatosis. N Engl J Med 295:1287-1291, 1976
4. Vasen HFA, van der Feltz M, Raue F, Nieuwenhuijzen Kruseman AC, Koppeschaar HPF, Pieters G, Seif FJ, Blum WF, Lips CJM: The natural course of multiple endocrine neoplasia 2b. Arch Intern Med 152:1250-1252, 1992
5. Demos TC, Blonder J, Schey WL, Braithwaite SS, Goldstein PL: Multiple endocrine neoplasia syndrome type 2b: Gastrointestinal manifestations. AJR 140:73-78, 1983
6. Griffiths AM, Mack DR, Byard RW, Stringer DA, Shandling B: Multiple endocrine neoplasia 2b: An unusual cause of chronic constipation. J Pediatr 116:285-288, 1990
7. Hofstra RMW, Landsvater RM, Ceccherini I: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2b and sporadic medullary thyroid carcinoma. Nature 367:375-376, 1994
8. Edery P, Lyonnet S, Mulligan LM: Mutations of the RET protooncogene associated in Hirschsprung's disease. Nature 367:378-380, 1994
9. Carr ND, Hulme A, Sheron N, Lees WR, Russell RCG: Intestinal ischemia associated with pheochromocytoma. Postgrad Med J 65:594-596, 1989
10. Bravo EL: Pheochromocytoma: new concepts and future trends. Kidney Int 40:544-556, 1991
11. Gray TK, Bieberdorf FA, Fordtran JS: Thyrocalcitonin and the jejunal absorption of calcium, water, and electrolytes in normal subjects. J Clin Invest 52:3084-3088, 1973
12. Cox TM, Fagan EA, Hilliyard CJ, Allison DJ, Chadwick VS: Role of calcitonin in diarrhea associated with medullary carcinoma of the thyroid. Gut 20:629-633, 1979
13. Bernier JJ, Rambaud JC, Cattan D, Prost A: Diarrhea associated with medullary carcinoma of the thyroid. Gut 10:980-985, 1969
14. Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H: Genetic testing in the diagnosis and management of multiple endocrine neoplasia type 2. Ann Intern Med 122:118-124, 1995
15. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D: External radiotherapy in thyroid cancers. Cancer 55:2062-2071, 1985
16. Nieuwenhuijzen Kruseman AC, Bussemaker JK, Frolich M: Radioiodine in the treatment of hereditary medullary carcinoma of the thyroid. J Clin Endocrinol Metab 59:491-494, 1984
17. Norton JA, Froome LC, Farrell RE, Wells SA: Multiple endocrine neoplasia type 2b: The most aggressive form of medullary thyroid carcinoma. Surg Clin North Am 59:109-118, 1979